Page 60 - AN-3-2
P. 60

Advanced Neurology                                               Inflammation in diabetic stroke: Pathogenesis



            52.  He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z. Oxidative      doi: 10.1186/1471-2377-11-110
               stress, inflammation, and autophagy: Potential targets of   62.  Suda S, Aoki J, Shimoyama T,  et al. Stroke-associated
               mesenchymal stem cells-based therapies in ischemic stroke.   infection independently predicts 3-month poor functional
               Front Neurosci. 2021;15:641157.                    outcome and mortality. J Neurol. 2018;265(2):370-375.
               doi: 10.3389/fnins.2021.641157                     doi: 10.1007/s00415-017-8714-6
            53.  O’Connell GC, Tennant CS, Lucke-Wold N, et al. Monocyte-  63.  Courties  G, Herisson F, Sager HB,  et al. Ischemic stroke
               lymphocyte cross-communication via soluble CD163   activates hematopoietic bone marrow stem cells. Circ Res.
               directly links innate immune system activation and adaptive   2015;116(3):407-417.
               immune system suppression following ischemic stroke. Sci
               Rep. 2017;7(1):12940.                              doi: 10.1161/CIRCRESAHA.116.305207
                                                               64.  Roth S, Cao J, Singh V, et al. Post-injury immunosuppression
               doi: 10.1038/s41598-017-13291-6
                                                                  and secondary infections are caused by an AIM2
            54.  Kim E, Tolhurst AT, Cho S. Deregulation of inflammatory   inflammasome-driven  signaling  cascade.  Immunity.
               response in the diabetic condition is associated with   2021;54(4):648-659.e8.
               increased ischemic brain injury.  J  Neuroinflammation.      doi: 10.1016/j.immuni.2021.02.004
               2014;11:83.
                                                               65.  Wang H, Deng QW, Peng AN,  et al.  β-arrestin2
               doi: 10.1186/1742-2094-11-83
                                                                  functions as a key regulator in the sympathetic-triggered
            55.  Bemeur C, Ste-Marie L, Montgomery J. Increased oxidative   immunodepression after stroke.  J  Neuroinflammation.
               stress during hyperglycemic cerebral ischemia. Neurochem   2018;15(1):102.
               Int. 2007;50(7-8):890-904.                         doi: 10.1186/s12974-018-1142-4
               doi: 10.1016/j.neuint.2007.03.002               66.  Jiang C, Kong W, Wang Y,  et al. Changes in the cellular
            56.  Louiselle AE, Niemiec SM, Zgheib C, Liechty KW.   immune system and circulating inflammatory markers of
               Macrophage polarization and diabetic wound healing.   stroke patients. Oncotarget. 2017;8(2):3553-3567.
               Transl Res. 2021;236:109-116.                      doi: 10.18632/oncotarget.12201
               doi: 10.1016/j.trsl.2021.05.006                 67.  Simats A, Liesz A. Systemic  inflammation  after  stroke:
            57.  Bemeur C, Ste-Marie L, Desjardins P, et al. Dehydroascorbic   Implications for post-stroke comorbidities. EMBO Mol Med.
               acid normalizes several markers of oxidative stress and   2022;14(9):e16269.
               inflammation in acute hyperglycemic focal cerebral ischemia      doi: 10.15252/emmm.202216269
               in the rat. Neurochem Int. 2005;46(5):399-407.
                                                               68.  Romer C, Engel O, Winek K,  et al. Blocking stroke-
               doi: 10.1016/j.neuint.2004.11.007                  induced immunodeficiency increases CNS antigen-specific
            58.  Ste-Marie L, Hazell AS, Bemeur C, Butterworth R,   autoreactivity but does not worsen functional outcome after
               Montgomery J. Immunohistochemical detection of     experimental stroke. J Neurosci. 2015;35(20):7777-7794.
               inducible nitric oxide synthase, nitrotyrosine and      doi: 10.1523/JNEUROSCI.1532-14.2015
               manganese superoxide dismutase following hyperglycemic   69.  Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2
               focal cerebral ischemia. Brain Res. 2001;918(1-2):10-19.
                                                                  diabetes and its impact on the immune system.  Curr
               doi: 10.1016/s0006-8993(01)02903-1                 Diabetes Rev. 2020;16(5):442-449.
            59.  Li PA, Shuaib A, Miyashita H, He QP, Siesjo BK, Warner DS.      doi: 10.2174/1573399815666191024085838
               Hyperglycemia  enhances  extracellular  glutamate  70.  Martinez  N,  Ketheesan  N,  Martens  GW,  West  K,  Lien  E,
               accumulation in rats subjected to forebrain ischemia. Stroke.   Kornfeld H. Defects in early cell recruitment contribute
               2000;31(1):183-192.                                to  the increased  susceptibility to  respiratory  Klebsiella
               doi: 10.1161/01.str.31.1.183                       pneumoniae infection in diabetic mice.  Microbes Infect.
                                                                  2016;18(10):649-655.
            60.  Wicha P, Das S, Mahakkanukrauh P. Blood-brain barrier
               dysfunction in ischemic stroke and diabetes: The underlying      doi: 10.1016/j.micinf.2016.05.007
               link, mechanisms and future possible therapeutic targets.   71.  Gupta S, Maratha A, Siednienko J,  et al. Analysis of
               Anat Cell Biol. 2021;54(2):165-177.                inflammatory cytokine and TLR expression levels in Type 2
               doi: 10.5115/acb.20.290                            Diabetes with complications. Sci Rep. 2017;7(1):7633.
            61.  Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG,      doi: 10.1038/s41598-017-07230-8
               van de Beek D. Post-stroke infection: A systematic review   72.  Mooradian AD, Reed RL, Meredith KE, Scuderi P. Serum
               and meta-analysis. BMC Neurol. 2011;11:110.        levels of tumor necrosis factor and IL-1 alpha and IL-1 beta


            Volume 3 Issue 2 (2024)                         10                               doi: 10.36922/an.1683
   55   56   57   58   59   60   61   62   63   64   65